Sofosbuvir and simeprevir without ribavirin effectively treat hepatitis C virus genotype 1 infection after liver transplantation in a two-center experience-Reference-Cited by-同舟云学术

Sofosbuvir and simeprevir without ribavirin effectively treat hepatitis C virus genotype 1 infection after liver transplantation in a two-center experience

Published:2016-04-24 Issue:6 Volume:30 Page:709-713
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Jackson Whitney E.¹,Hanouneh Mohamad²,Apfel Tehilla²,Alkhouri Naim¹,John Binu V.¹,Zervos Xaralambos³,Zein Nizar N.¹,Hanouneh Ibrahim A.¹

Affiliation:

1. Department of Gastroenterology and Hepatology; Cleveland Clinic; Cleveland OH USA

2. Department of Internal Medicine; Cleveland Clinic; Cleveland OH USA

3. Department of Gastroenterology and Hepatology; Cleveland Clinic Florida; Weston FL USA

Publisher

Wiley

Subject

Transplantation

Reference25 articles.

1. Recurrent and acquired hepatitis C viral infection in liver transplant recipients;Wright;Gastroenterology,1992

2. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation;Dickson;Transplantation,1996

3. Natural history of recurrent hepatitis C;Berenguer;Liver Transpl,2002

4. Hepatitis C virus kinetics during and immediately after liver transplantation;Garcia-Retortillo;Hepatology,2002

5. Liver fibrosis progression in hepatitis C virus infection after seroconversion;Butt;JAMA Intern Med,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Transplant Patients Infected with HCV;Hepatitis C: Care and Treatment;2021

2. Management of HCV Infection After Liver Transplantation;Evidence-based Gastroenterology and Hepatology 4e;2019-02-27

3. Direct‐acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta‐analysis;Transplant Infectious Disease;2019-01-21

4. Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study;Alimentary Pharmacology & Therapeutics;2018-04-17

5. Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates;World Journal of Gastroenterology;2018-01-21